Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of tanshinlactone in preparation of anti-tumor-angiogenesis medicament

An angiogenesis and anti-tumor technology, applied in anti-tumor drugs, drug combinations, pharmaceutical formulations, etc.

Inactive Publication Date: 2012-09-19
KUNMING UNIV OF SCI & TECH
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In terms of pharmacological activity, there is no report on the study of salvianolide alone as a pharmacologically active ingredient

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of tanshinlactone in preparation of anti-tumor-angiogenesis medicament
  • Application of tanshinlactone in preparation of anti-tumor-angiogenesis medicament
  • Application of tanshinlactone in preparation of anti-tumor-angiogenesis medicament

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Example 1: Preparation of salvianolide (the salvianolide used in the following examples was prepared by the following method)

[0020] Using Salvia yunnanensis (Labiatae sage) Salvia yunnanensis C. H. Wright) 10 kg of dried roots or rhizomes, crushed into coarse powder, extracted by cold immersion in 25L of acetone, repeated three times, concentrated to obtain crude extract; the extract was made into suspension with water, extracted with ethyl acetate to obtain ethyl acetate Section; this section adopts silica gel column chromatography, petroleum ether-ethyl acetate gradient elution, obtains 5 partial elution sections, wherein 9:1 elution part adopts silica gel chromatography column again, chloroform-acetone gradient elution (using successively 8:1, 5:1, 3:1 elution), the 5:1 elution fraction was eluted with RP-C 18 Column chromatography methanol-water gradient elution (elution with 80:20, 85:15 in sequence), the fraction eluted at 85:15 was separated and purified by...

Embodiment 2

[0027] Example 2: Effect of salvianolide on the proliferation of human liver cancer cell line HepG-2

[0028] The human liver cancer cell line HepG-2 was incubated at 37°C in 5% CO 2 Cultivate for 24 hours, inoculate it into a 96-well plate according to the inoculation amount of 3000 per well, and after culturing for 24 hours under the above conditions, make salvianolide into different concentrations of 0.5, 1.0, 2.5, 5.0, 10.0ug / mL Concentration solution was added to a 96-well plate, at 37°C, 5% CO 2 The culture was continued for 72 hours under certain conditions, the supernatant was carefully removed, 150 μL DMSO was added to each well, shaken for 1 hour, and the absorbance A value was measured at 490 nm on a microplate reader.

[0029] Such as figure 2 The results showed that the absorbance of the MTT experiment decreased significantly when the salvianolide concentration was 5.0ug / mL and 10ug / mL, indicating that the proliferation activity of tumor cells decreased sign...

Embodiment 3

[0033] Embodiment 3: chicken embryo allantoic membrane experiment of salvianolide, concrete operation is as follows:

[0034] 1. Purchase fresh eggs produced within three days, wipe and disinfect the surface of the eggs with 84 disinfectant or bromogeramine, then put the eggs into a constant temperature incubator, set the temperature at 37.8°C, and maintain a certain humidity (60%). Under this condition Incubate for 7 days.

[0035] 2. Opening the window and administering the drug

[0036] 2.1 Preparation of blank control solution, positive control solution and salvianolide solution: (1) Preparation of blank control solution: use blank saline as a control; (2) Preparation of positive control solution: use 5 mg / mL dexamethasone sodium phosphate injection as a positive control ; (3) Preparation of Salvia lactone solution: Accurately weigh 2 mg of Salvia lactone and configure it with absolute ethanol to make a 1 mg / mL mother liquor for later use, use the above mother liquor to dil...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of tanshinlactone in the preparation of an anti-tumor-angiogenesis medicament. According to an experimental result, by taking the tanshinlactone as an angiogenesis antagonist, an anti-angiogenesis effect can be achieved, and tumor growth, particularly pathological tumor growth related to or caused by angiogenesis is inhibited by inhibiting the angiogenesis in tumor tissues.

Description

technical field [0001] The invention relates to a new application of tanshinlactone, especially relates to its application in the preparation of anti-tumor angiogenesis drugs, and belongs to the field of anti-angiogenesis compounds. Background technique [0002] Tumor angiogenesis is a highly regulated process that occurs for a short period and is then completely terminated. Tumor growth and metastasis depend on angiogenesis. The first experiment to confirm the theory that tumors produce vascular growth factors is the experiment of Greenblatt et al. transplanting melanoma or uterine choriocarcinoma cells to promote vascular proliferation; the results show that tumor cell proliferation is closely related to vascular Formation is closely related, thus providing evidence that tumor angiogenesis is mediated by diffusible factors produced by tumor cells. Following formation of the main vascular plexus, these endothelial cells form new capillaries by budding or dividing from pree...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/58A61P35/00
Inventor 向诚张林东李鹏李宝才庄文婷何静戴伟锋角仕云
Owner KUNMING UNIV OF SCI & TECH